Details for: FABP5

Gene ID: 2171

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: FABP5

Ensembl ID: ENSG00000164687

Description: fatty acid binding protein 5

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • granulocyte monocyte progenitor cell CL0000557
    CSI 68.64
    rCSI 59.43%
    PRS 16.58
  • epithelial cell of lower respiratory tract CL0002632
    CSI 67.27
    rCSI 52.15%
    PRS 14.08
  • elicited macrophage CL0000861
    CSI 65.32
    rCSI 59.98%
    PRS 17.03
  • common myeloid progenitor CL0000049
    CSI 58.53
    rCSI 47.33%
    PRS 14.67
  • conjunctival epithelial cell CL1000432
    CSI 56.34
    rCSI 86.05%
    PRS 14.8
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 49.11
    rCSI 44.35%
    PRS 13.16
  • common dendritic progenitor CL0001029
    CSI 45.33
    rCSI 56.89%
    PRS 18.93
  • peripheral nervous system neuron CL2000032
    CSI 45.31
    rCSI 61.74%
    PRS 13.18
  • transit amplifying cell of colon CL0009011
    CSI 44.29
    rCSI 52.02%
    PRS 17.31
  • stem cell CL0000034
    CSI 42.27
    rCSI 40.76%
    PRS 10.4
  • promyelocyte CL0000836
    CSI 39.07
    rCSI 56.36%
    PRS 20.6
  • hematopoietic stem cell CL0000037
    CSI 38.21
    rCSI 25.4%
    PRS 17.71
  • Hofbauer cell CL3000001
    CSI 37.45
    rCSI 70.7%
    PRS 18.44
  • alveolar macrophage CL0000583
    CSI 35.1
    rCSI 57.82%
    PRS 17.29
  • alternatively activated macrophage CL0000890
    CSI 35.07
    rCSI 44.09%
    PRS 22.63
  • club cell CL0000158
    CSI 31.66
    rCSI 46.37%
    PRS 17.18
  • keratinocyte CL0000312
    CSI 31.61
    rCSI 26.49%
    PRS 17.65
  • foveolar cell of stomach CL0002179
    CSI 31.27
    rCSI 66.56%
    PRS 23.72
  • early lymphoid progenitor CL0000936
    CSI 30.78
    rCSI 27.03%
    PRS 16.7
  • pulmonary alveolar type 2 cell CL0002063
    CSI 28.23
    rCSI 43.79%
    PRS 22.36
  • fraction A pre-pro B cell CL0002045
    CSI 28.1
    rCSI 32.17%
    PRS 30.08
  • glioblast CL0000030
    CSI 27.88
    rCSI 44.48%
    PRS 12.73
  • epithelial cell of lung CL0000082
    CSI 25.42
    rCSI 21.07%
    PRS 13.92
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 24.85
    rCSI 17.84%
    PRS 20.17
  • transit amplifying cell CL0009010
    CSI 24.63
    rCSI 37.66%
    PRS 23.96
  • forebrain radial glial cell CL0013000
    CSI 24.31
    rCSI 78.02%
    PRS 21.42
  • pancreatic A cell CL0000171
    CSI 23.16
    rCSI 24.26%
    PRS 15.78
  • radial glial cell CL0000681
    CSI 22.58
    rCSI 31.36%
    PRS 15.21
  • promonocyte CL0000559
    CSI 22.32
    rCSI 38.24%
    PRS 19.94
  • intestinal epithelial cell CL0002563
    CSI 21.89
    rCSI 22.88%
    PRS 15.45
  • capillary endothelial cell CL0002144
    CSI 21.39
    rCSI 39.21%
    PRS 53.08
  • endothelial cell of artery CL1000413
    CSI 21.05
    rCSI 30.84%
    PRS 61.62
  • epithelial cell CL0000066
    CSI 19.94
    rCSI 30.65%
    PRS 20.77
  • corneal epithelial cell CL0000575
    CSI 19.67
    rCSI 56.28%
    PRS 26.03
  • respiratory hillock cell CL4030023
    CSI 19.33
    rCSI 34.47%
    PRS 24.95
  • microcirculation associated smooth muscle cell CL0008035
    CSI 19.25
    rCSI 55.74%
    PRS 16.76
  • duct epithelial cell CL0000068
    CSI 18.8
    rCSI 27.51%
    PRS 15.6
  • mucous neck cell CL0000651
    CSI 18.2
    rCSI 26.24%
    PRS 23.58
  • nasal mucosa goblet cell CL0002480
    CSI 17.61
    rCSI 20.42%
    PRS 21.78
  • pancreatic D cell CL0000173
    CSI 17.27
    rCSI 16.99%
    PRS 16.05
  • large pre-B-II cell CL0000957
    CSI 16.84
    rCSI 48.06%
    PRS 25.25
  • endothelial cell of lymphatic vessel CL0002138
    CSI 16.71
    rCSI 33.12%
    PRS 42.24
  • stromal cell CL0000499
    CSI 16.55
    rCSI 46.56%
    PRS 20.72
  • plasmablast CL0000980
    CSI 16.42
    rCSI 12.92%
    PRS 17.65
  • enteroendocrine cell CL0000164
    CSI 15.85
    rCSI 21.66%
    PRS 16.37
  • respiratory suprabasal cell CL4033048
    CSI 15.73
    rCSI 20.18%
    PRS 17.06
  • tracheal goblet cell CL1000329
    CSI 15.59
    rCSI 34.05%
    PRS 29.52
  • mesodermal cell CL0000222
    CSI 15.53
    rCSI 18.64%
    PRS 14.56
  • neural crest cell CL0011012
    CSI 15.23
    rCSI 12.04%
    PRS 10.16
  • pancreatic PP cell CL0002275
    CSI 15.05
    rCSI 59.92%
    PRS 25.84
  • colon epithelial cell CL0011108
    CSI 15.05
    rCSI 15.76%
    PRS 13.74
  • precursor B cell CL0000817
    CSI 15
    rCSI 13.14%
    PRS 19.58
  • type L enteroendocrine cell CL0002279
    CSI 14.58
    rCSI 27.37%
    PRS 28.91
  • pro-B cell CL0000826
    CSI 14.1
    rCSI 11.68%
    PRS 14.82
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 13.91
    rCSI 16.07%
    PRS 12.97
  • lung macrophage CL1001603
    CSI 13.41
    rCSI 29.96%
    PRS 16.87
  • fallopian tube secretory epithelial cell CL4030006
    CSI 13.39
    rCSI 12.89%
    PRS 15.29
  • intestine goblet cell CL0019031
    CSI 13.19
    rCSI 11.71%
    PRS 14.76
  • type EC enteroendocrine cell CL0000577
    CSI 12.36
    rCSI 43.87%
    PRS 24.1
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 11.94
    rCSI 14.42%
    PRS 17.49
  • lung endothelial cell CL1001567
    CSI 11.43
    rCSI 26.65%
    PRS 34.7
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 11.32
    rCSI 58.44%
    PRS 28.8
  • retinal blood vessel endothelial cell CL0002585
    CSI 10.93
    rCSI 17.45%
    PRS 16.2
  • acinar cell CL0000622
    CSI 10.73
    rCSI 15.74%
    PRS 19.39
  • common lymphoid progenitor CL0000051
    CSI 10.73
    rCSI 14.34%
    PRS 28.15
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 10.71
    rCSI 18.33%
    PRS 29.56
  • cardiac endothelial cell CL0010008
    CSI 10.64
    rCSI 42.93%
    PRS 13.17
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 10.61
    rCSI 10.42%
    PRS 23.15
  • basal cell CL0000646
    CSI 10.35
    rCSI 13.84%
    PRS 16.17
  • goblet cell CL0000160
    CSI 10.18
    rCSI 9.62%
    PRS 15.41
  • double negative thymocyte CL0002489
    CSI 9.96
    rCSI 6.93%
    PRS 17.39
  • endothelial cell of arteriole CL1000412
    CSI 9.88
    rCSI 54.82%
    PRS 41.33
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 9.82
    rCSI 7.47%
    PRS 19.39
  • enteric smooth muscle cell CL0002504
    CSI 9.78
    rCSI 13.96%
    PRS 16.63
  • endothelial cell of placenta CL0009092
    CSI 9.75
    rCSI 48.06%
    PRS 20.05
  • mature T cell CL0002419
    CSI 9.62
    rCSI 7.48%
    PRS 21.37
  • Kupffer cell CL0000091
    CSI 9.6
    rCSI 21.95%
    PRS 14.33
  • vein endothelial cell CL0002543
    CSI 9.59
    rCSI 26.18%
    PRS 53.55
  • multi-ciliated epithelial cell CL0005012
    CSI 9.56
    rCSI 9.54%
    PRS 12.61
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 9.33
    rCSI 8.63%
    PRS 26.87
  • granulocyte CL0000094
    CSI 9.08
    rCSI 13.87%
    PRS 18.76
  • macrophage CL0000235
    CSI 9.06
    rCSI 16.48%
    PRS 54.11
  • extravillous trophoblast CL0008036
    CSI 9
    rCSI 11.13%
    PRS 12.95
  • cerebral cortex GABAergic interneuron CL0010011
    CSI 8.57
    rCSI 25.3%
    PRS 17.92
  • perivascular cell CL4033054
    CSI 8.44
    rCSI 11.54%
    PRS 16.74
  • enteroendocrine cell of colon CL0009042
    CSI 8.44
    rCSI 39.58%
    PRS 38.33
  • conventional dendritic cell CL0000990
    CSI 8.41
    rCSI 7.02%
    PRS 41.29
  • Schwann cell CL0002573
    CSI 8.38
    rCSI 23.83%
    PRS 17.45
  • basophil mast progenitor cell CL0002028
    CSI 8.21
    rCSI 43.79%
    PRS 51.65
  • mononuclear phagocyte CL0000113
    CSI 8.08
    rCSI 17.78%
    PRS 16.45
  • vein endothelial cell of respiratory system CL4033008
    CSI 7.9
    rCSI 54.24%
    PRS 28.75
  • T follicular helper cell CL0002038
    CSI 7.74
    rCSI 5.79%
    PRS 23.89
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 7.63
    rCSI 19.88%
    PRS 13.54
  • dendritic cell CL0000451
    CSI 7.61
    rCSI 9.38%
    PRS 45.05
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 7.56
    rCSI 7.43%
    PRS 41.39
  • interneuron CL0000099
    CSI 7.39
    rCSI 14.84%
    PRS 10.94
  • intestinal crypt stem cell of colon CL0009043
    CSI 7.39
    rCSI 55.48%
    PRS 26.84
  • blood vessel endothelial cell CL0000071
    CSI 7.36
    rCSI 15.27%
    PRS 14.75
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 7.24
    rCSI 9.29%
    PRS 14.38
  • metallothionein-positive alveolar macrophage CL4033042
    CSI 7.22
    rCSI 78.55%
    PRS 53.37
  • paneth cell of epithelium of small intestine CL1000343
    CSI -4.2
    rCSI -11.6%
    PRS 22.8%
  • IgM plasma cell CL0000986
    CSI -2.8
    rCSI -12.6%
    PRS 61.2%
  • mature astrocyte CL0002627
    CSI -1.5
    rCSI -6.2%
    PRS 18.2%
  • suprabasal keratinocyte CL4033013
    CSI -1.2
    rCSI -1.9%
    PRS 8.6%
  • retinal ganglion cell CL0000740
    CSI -0.5
    rCSI -1.1%
    PRS 10.6%
  • myelocyte CL0002193
    CSI -0.5
    rCSI -3.1%
    PRS 45.4%
  • cerebellar granule cell CL0001031
    CSI -0.3
    rCSI -0.5%
    PRS 13.6%
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI -0.3
    rCSI -1.2%
    PRS 8.1%
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 0.0
    rCSI 0.1%
    PRS 32.8%
  • peptic cell CL0000155
    CSI 0.0
    rCSI 0.2%
    PRS 41.4%
  • type B pancreatic cell CL0000169
    CSI 0.2
    rCSI 0.3%
    PRS 13.7%
  • small pre-B-II cell CL0000954
    CSI 0.2
    rCSI 0.2%
    PRS 30.3%
  • parietal cell CL0000162
    CSI 0.2
    rCSI 1.6%
    PRS 64.4%
  • osteoblast CL0000062
    CSI 0.2
    rCSI 5.3%
    PRS 77.7%
  • placental villous trophoblast CL2000060
    CSI 0.3
    rCSI 0.5%
    PRS 13.8%
  • cord blood hematopoietic stem cell CL2000095
    CSI 0.3
    rCSI 6.1%
    PRS 74.9%
  • L6b glutamatergic cortical neuron CL4023038
    CSI 0.3
    rCSI 1.0%
    PRS 9.3%
  • chondrocyte CL0000138
    CSI 0.3
    rCSI 0.5%
    PRS 12.6%
  • pulmonary ionocyte CL0017000
    CSI 0.4
    rCSI 0.4%
    PRS 18.6%
  • P/D1 enteroendocrine cell CL0002268
    CSI 0.4
    rCSI 2.1%
    PRS 35.8%
  • retinal cone cell CL0000573
    CSI 0.4
    rCSI 0.7%
    PRS 11.4%
  • CD34-positive, CD56-positive, CD117-positive common innate lymphoid precursor, human CL0001074
    CSI 0.5
    rCSI 5.6%
    PRS 53.5%
  • mammary gland epithelial cell CL0002327
    CSI 0.5
    rCSI 1.7%
    PRS 26.5%
  • ventricular cardiac muscle cell CL2000046
    CSI 0.5
    rCSI 1.8%
    PRS 53.6%
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 0.7
    rCSI 2.5%
    PRS 8.9%
  • astrocyte of the cerebral cortex CL0002605
    CSI 0.7
    rCSI 1.5%
    PRS 9.1%
  • cytotoxic T cell CL0000910
    CSI 0.7
    rCSI 3.9%
    PRS 21.5%
  • neuroplacodal cell CL0000032
    CSI 0.7
    rCSI 6.7%
    PRS 40.2%
  • mature B cell CL0000785
    CSI 0.8
    rCSI 0.7%
    PRS 18.3%
  • endothelial cell of uterus CL0009095
    CSI 0.8
    rCSI 5.8%
    PRS 39.4%
  • primitive red blood cell CL0002355
    CSI 0.8
    rCSI 4.3%
    PRS 27.1%
  • helper T cell CL0000912
    CSI 0.8
    rCSI 1.1%
    PRS 20.5%
  • pancreatic epsilon cell CL0005019
    CSI 0.8
    rCSI 3.8%
    PRS 34.3%
  • prostate gland microvascular endothelial cell CL2000059
    CSI 0.8
    rCSI 19.9%
    PRS 47.6%
  • lung microvascular endothelial cell CL2000016
    CSI 0.9
    rCSI 17.2%
    PRS 44.1%
  • blood vessel smooth muscle cell CL0019018
    CSI 0.9
    rCSI 7.3%
    PRS 15.2%
  • podocyte CL0000653
    CSI 0.9
    rCSI 4.2%
    PRS 14.5%
  • epithelial cell of urethra CL1000296
    CSI 1.0
    rCSI 25.2%
    PRS 44.5%
  • mesenchymal lymphangioblast CL0005021
    CSI 1.1
    rCSI 27.8%
    PRS 60.2%
  • endothelial cell of vascular tree CL0002139
    CSI 1.1
    rCSI 6.2%
    PRS 24.6%
  • pancreatic acinar cell CL0002064
    CSI 1.2
    rCSI 1.6%
    PRS 16.2%
  • IgG plasma cell CL0000985
    CSI 1.2
    rCSI 1.5%
    PRS 25.6%
  • BEST4+ enteroycte CL4030026
    CSI 1.2
    rCSI 1.5%
    PRS 15.6%
  • enterocyte of epithelium of large intestine CL0002071
    CSI 1.3
    rCSI 6.7%
    PRS 25.9%
  • epithelial cell of nephron CL1000449
    CSI 1.3
    rCSI 12.2%
    PRS 56.8%
  • uterine smooth muscle cell CL0002601
    CSI 1.4
    rCSI 9.2%
    PRS 68.5%
  • endothelial cell of periportal hepatic sinusoid CL0019021
    CSI 1.5
    rCSI 6.8%
    PRS 38.2%
  • lung ciliated cell CL1000271
    CSI 1.5
    rCSI 1.7%
    PRS 10.8%
  • ionocyte CL0005006
    CSI 1.5
    rCSI 1.6%
    PRS 13.6%
  • colonocyte CL1000347
    CSI 1.5
    rCSI 2.2%
    PRS 20.3%
  • OFF-bipolar cell CL0000750
    CSI 1.5
    rCSI 2.1%
    PRS 23.8%
  • cardiac blood vessel endothelial cell CL0010006
    CSI 1.6
    rCSI 11.3%
    PRS 16.5%
  • intermediate monocyte CL0002393
    CSI 1.6
    rCSI 2.4%
    PRS 14.7%
  • myeloid dendritic cell, human CL0001057
    CSI 1.6
    rCSI 9.0%
    PRS 45.6%
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 1.7
    rCSI 2.6%
    PRS 35.2%
  • macroglial cell CL0000126
    CSI 1.8
    rCSI 4.6%
    PRS 20.2%
  • cell of skeletal muscle CL0000188
    CSI 1.8
    rCSI 19.4%
    PRS 64.7%
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI 1.8
    rCSI 3.3%
    PRS 12.1%
  • pulmonary alveolar type 1 cell CL0002062
    CSI 1.8
    rCSI 10.5%
    PRS 19.2%
  • VIP GABAergic cortical interneuron CL4023016
    CSI 1.8
    rCSI 2.2%
    PRS 8.5%
  • hair follicular keratinocyte CL2000092
    CSI 1.9
    rCSI 32.2%
    PRS 54.8%
  • paneth cell of colon CL0009009
    CSI 1.9
    rCSI 18.2%
    PRS 40.3%
  • antibody secreting cell CL0000946
    CSI 1.9
    rCSI 8.6%
    PRS 56.0%
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 2.0
    rCSI 1.5%
    PRS 13.5%
  • bronchial goblet cell CL1000312
    CSI 2.0
    rCSI 7.9%
    PRS 31.8%
  • fibroblast of breast CL4006000
    CSI 2.0
    rCSI 8.4%
    PRS 37.1%
  • kidney epithelial cell CL0002518
    CSI 2.0
    rCSI 3.9%
    PRS 33.6%
  • small intestine goblet cell CL1000495
    CSI 2.0
    rCSI 4.5%
    PRS 19.7%
  • erythroblast CL0000765
    CSI 2.1
    rCSI 5.5%
    PRS 24.1%
  • primordial germ cell CL0000670
    CSI 2.1
    rCSI 10.5%
    PRS 67.4%
  • hepatocyte CL0000182
    CSI 2.1
    rCSI 3.8%
    PRS 13.7%
  • deuterosomal cell CL4033044
    CSI 2.2
    rCSI 7.4%
    PRS 24.3%
  • activated CD4-positive, alpha-beta T cell, human CL0001043
    CSI 2.3
    rCSI 5.4%
    PRS 66.8%
  • endothelial cell of venule CL1000414
    CSI 2.3
    rCSI 20.1%
    PRS 53.5%
  • ependymal cell CL0000065
    CSI 2.3
    rCSI 4.7%
    PRS 6.6%
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 2.3
    rCSI 4.4%
    PRS 32.0%
  • pluripotent stem cell CL0002248
    CSI 2.4
    rCSI 70.8%
    PRS 33.2%
  • pancreatic stellate cell CL0002410
    CSI 2.4
    rCSI 13.8%
    PRS 22.2%
  • mesenchymal cell CL0008019
    CSI 2.4
    rCSI 6.1%
    PRS 14.9%
  • basal cell of epidermis CL0002187
    CSI 2.4
    rCSI 4.3%
    PRS 13.6%
  • interstitial cell of Cajal CL0002088
    CSI 2.5
    rCSI 3.1%
    PRS 17.2%
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 2.5
    rCSI 6.7%
    PRS 19.0%
  • megakaryocyte progenitor cell CL0000553
    CSI 2.5
    rCSI 45.7%
    PRS 42.2%
  • endocrine cell CL0000163
    CSI 2.5
    rCSI 12.8%
    PRS 54.5%
  • glutamatergic neuron CL0000679
    CSI 2.5
    rCSI 5.2%
    PRS 14.8%
  • Bergmann glial cell CL0000644
    CSI 2.5
    rCSI 3.4%
    PRS 14.8%
  • keratocyte CL0002363
    CSI 2.5
    rCSI 6.1%
    PRS 22.1%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 2.6
    rCSI 1.8%
    PRS 17.8%
  • intestinal tuft cell CL0019032
    CSI 2.8
    rCSI 4.3%
    PRS 16.9%
  • innate lymphoid cell CL0001065
    CSI 2.9
    rCSI 5.9%
    PRS 22.3%
  • retina horizontal cell CL0000745
    CSI 2.9
    rCSI 4.4%
    PRS 13.8%
  • forebrain neuroblast CL1000042
    CSI 2.9
    rCSI 31.2%
    PRS 84.8%
  • megakaryocyte CL0000556
    CSI 2.9
    rCSI 12.7%
    PRS 26.2%
  • lung resident memory CD8-positive, alpha-beta T cell CL4033039
    CSI 3.0
    rCSI 7.6%
    PRS 37.9%
  • IgA plasma cell CL0000987
    CSI 3.0
    rCSI 3.1%
    PRS 27.4%
  • vasa recta ascending limb cell CL1001131
    CSI 3.0
    rCSI 13.7%
    PRS 49.9%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 3.1
    rCSI 3.8%
    PRS 19.2%
  • thymocyte CL0000893
    CSI 3.2
    rCSI 11.3%
    PRS 45.0%
  • neural progenitor cell CL0011020
    CSI 3.2
    rCSI 14.1%
    PRS 14.2%
  • pancreatic ductal cell CL0002079
    CSI 3.2
    rCSI 6.3%
    PRS 15.1%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [FABP5](/details-gene/2171) (Fatty Acid Binding Protein 5) is a protein-coding gene located on chromosome 8q21.13. It encodes a small intracellular lipid-binding protein that plays a central role in the transport and metabolism of fatty acids and other lipophilic molecules, such as endocannabinoids and retinoic acid. The expression profile of [FABP5](/details-gene/2171) suggests a dual role in both epithelial barrier function and myeloid cell development. Its high significance in various progenitor cells, including [granulocyte monocyte progenitor cell](/details-cell/CL0000557) and [common myeloid progenitor](/details-cell/CL0000049), as well as in epithelial cells of the respiratory tract, points to its involvement in cellular differentiation and tissue homeostasis. Its initial discovery as a highly upregulated protein in psoriatic skin underscores its relevance in inflammatory and hyperproliferative conditions [Link](https://doi.org/10.1111/1523-1747.ep12616641). ## Cellular Roles and Expression Landscape The **Overall** expression pattern of [FABP5](/details-gene/2171) highlights its significant role within two primary biological systems: the hematopoietic myeloid lineage and various epithelial tissues. In the hematopoietic system, [FABP5](/details-gene/2171) demonstrates high significance in a spectrum of myeloid progenitor cells, including [granulocyte monocyte progenitor cell](/details-cell/CL0000557), [common myeloid progenitor](/details-cell/CL0000049), [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050), and [hematopoietic stem cell](/details-cell/CL0000037). This pattern is extended to more differentiated myeloid cells such as [elicited macrophage](/details-cell/CL0000861) and [alveolar macrophage](/details-cell/CL0000583), suggesting a sustained requirement for [FABP5](/details-gene/2171)-mediated lipid management throughout myeloid differentiation and mature macrophage function. Concurrently, [FABP5](/details-gene/2171) is a key gene in several epithelial populations, with top significance scores in [epithelial cell of lower respiratory tract](/details-cell/CL0002632) and [conjunctival epithelial cell](/details-cell/CL1000432). Its expression in [stem cell](/details-cell/CL0000034) and [transit amplifying cell of colon](/details-cell/CL0009011) further indicates a role in the maintenance and proliferation of tissues with high turnover rates. Conversely, the gene shows low to negligible significance in highly specialized cell types. This includes intestinal [paneth cell of epithelium of small intestine](/details-cell/CL1000343), terminally differentiated lymphoid cells like [IgM plasma cell](/details-cell/CL0000986), and various neuronal populations such as [cerebellar granule cell](/details-cell/CL0001031) and [mature astrocyte](/details-cell/CL0002627). This specificity suggests that its functions are primarily directed towards myeloid and specific epithelial contexts, rather than being a universal component of lipid metabolism across all cell types. ## Pathways and Molecular Function The functions of [FABP5](/details-gene/2171) are deeply rooted in lipid metabolism and transport. Gene Ontology annotations confirm its core molecular function as `[GO:0005504](https://www.ebi.ac.uk/QuickGO/term/GO:0005504)` (Fatty acid binding) and its involvement in the biological process of `[GO:0015908](https://www.ebi.ac.uk/QuickGO/term/GO:0015908)` (Fatty acid transport). Its role extends to the transport of specific lipids, including long-chain fatty acids (`[GO:0015909](https://www.ebi.ac.uk/QuickGO/term/GO:0015909)`) and retinoic acid (`[GO:0001972](https://www.ebi.ac.uk/QuickGO/term/GO:0001972)`). This functional profile is consistent with its cellular expression pattern. Its role in `[GO:0008544](https://www.ebi.ac.uk/QuickGO/term/GO:0008544)` (Epidermis development) and the Reactome pathway `[R-HSA-9725554](https://reactome.org/content/detail/R-HSA-9725554)` (Differentiation of keratinocytes in interfollicular epidermis in mammalian skin) directly aligns with its high expression in epithelial cells and its known association with skin disorders. For myeloid cells, its annotation for `[R-HSA-6798695](https://reactome.org/content/detail/R-HSA-6798695)` (Neutrophil degranulation) and its localization to the `[GO:0035578](https://www.ebi.ac.uk/QuickGO/term/GO:0035578)` (Azurophil granule lumen) provides a mechanistic link to its importance in myeloid cell function. Furthermore, [FABP5](/details-gene/2171) is implicated in complex signaling pathways. It participates in `[R-HSA-9006931](https://reactome.org/content/detail/R-HSA-9006931)` (Signaling by nuclear receptors) and positively regulates peroxisome proliferator-activated receptor (PPAR) signaling (`[GO:0035360](https://www.ebi.ac.uk/QuickGO/term/GO:0035360)`), indicating it acts as a shuttle for fatty acid ligands to nuclear receptors, thereby influencing gene transcription. Notably, it is also involved in `[GO:0098921](https://www.ebi.ac.uk/QuickGO/term/GO:0098921)` (Retrograde trans-synaptic signaling by endocannabinoid), a role supported by research demonstrating its ability to transport endocannabinoids [Link](https://doi.org/10.1074/jbc.m111.304907). ## Research Directions The expression and functional data for [FABP5](/details-gene/2171) suggest it is a critical hub integrating lipid metabolism with cellular differentiation and inflammation. Future research could focus on dissecting these roles in specific physiological and pathological contexts. ### Proposed Hypotheses: 1. **[FABP5](/details-gene/2171) is essential for myeloid lineage commitment and macrophage functional polarization.** Its high expression in myeloid progenitors suggests it controls the availability of specific fatty acids required for membrane expansion and the synthesis of signaling lipids that drive differentiation. In mature macrophages, it may selectively channel fatty acids towards either pro-inflammatory (M1) or anti-inflammatory (M2) metabolic programs. 2. **In the lower respiratory tract, [FABP5](/details-gene/2171) coordinates lipid homeostasis between [alveolar macrophage](/details-cell/CL0000583)s and [epithelial cell of lower respiratory tract](/details-cell/CL0002632)s to maintain surfactant integrity and regulate inflammatory responses.** It may facilitate the recycling of surfactant-derived lipids in macrophages or provide epithelial cells with precursors for surfactant synthesis, making it a key player in pulmonary health. ### Experimental Approach: To test the first hypothesis regarding myeloid differentiation, a robust experimental plan could be implemented. One could utilize CRISPR-Cas9 to knock out [FABP5](/details-gene/2171) in primary human CD34+ hematopoietic stem and progenitor cells. These modified cells would then be cultured in vitro with cytokine cocktails that promote differentiation towards the granulocyte-monocyte lineage. The impact of [FABP5](/details-gene/2171) deletion would be assessed by multi-parameter flow cytometry to quantify differentiation markers (e.g., CD14, CD11b, CD15) and by single-cell RNA sequencing to map differentiation trajectories and identify compensatory metabolic pathway changes. Functional assays, such as phagocytosis or cytokine production in response to LPS, could be performed on the resulting macrophages. ### Therapeutic Potential: Given its established upregulation in psoriasis and its role in shuttling pro-inflammatory lipid mediators and activating nuclear receptors like PPARs, [FABP5](/details-gene/2171) presents a compelling target for therapeutic **inhibition**. Its intracellular nature makes it amenable to targeting with small molecule inhibitors. Such inhibitors could be developed to treat inflammatory skin diseases by reducing keratinocyte proliferation and immune cell activation. Furthermore, because many cancers exhibit dysregulated lipid metabolism, targeting [FABP5](/details-gene/2171) could also represent a novel strategy to disrupt tumor growth in malignancies dependent on fatty acid uptake and signaling.

Genular Protein ID: 358276115

Symbol: FABP5_HUMAN

Name: Fatty acid-binding protein, epidermal

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 1512466

Title: Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins.

PubMed ID: 1512466

DOI: 10.1111/1523-1747.ep12616641

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 12665801

Title: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.

PubMed ID: 12665801

DOI: 10.1038/nbt810

PubMed ID: 1286667

Title: Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes.

PubMed ID: 1286667

DOI: 10.1002/elps.11501301199

PubMed ID: 8092987

Title: Purification and characterization of the human epidermal fatty acid-binding protein: localization during epidermal cell differentiation in vivo and in vitro.

PubMed ID: 8092987

DOI: 10.1042/bj3020363

PubMed ID: 15592455

Title: Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

PubMed ID: 15592455

DOI: 10.1038/nbt1046

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 19608861

Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.

PubMed ID: 19608861

DOI: 10.1126/science.1175371

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21395585

Title: Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells.

PubMed ID: 21395585

DOI: 10.1111/j.1471-4159.2011.07245.x

PubMed ID: 22170058

Title: Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors.

PubMed ID: 22170058

DOI: 10.1074/jbc.m111.304907

PubMed ID: 22223895

Title: Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.

PubMed ID: 22223895

DOI: 10.1074/mcp.m111.015131

PubMed ID: 22814378

Title: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

PubMed ID: 22814378

DOI: 10.1073/pnas.1210303109

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

PubMed ID: 10493790

Title: Expression, purification and crystal structure determination of recombinant human epidermal-type fatty acid-binding protein.

PubMed ID: 10493790

DOI: 10.1021/bi990305u

PubMed ID: 12049637

Title: Solution structure and backbone dynamics of human epidermal-type fatty acid-binding protein (E-FABP).

PubMed ID: 12049637

DOI: 10.1042/bj20020039

PubMed ID: 24692551

Title: Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor beta/delta (FABP5-PPARbeta/delta) signaling pathway.

PubMed ID: 24692551

DOI: 10.1074/jbc.m113.514646

PubMed ID: 24531463

Title: Crystallographic study of FABP5 as an intracellular endocannabinoid transporter.

PubMed ID: 24531463

DOI: 10.1107/s1399004713026795

Sequence Information:

  • Length: 135
  • Mass: 15164
  • Checksum: 77D38F8806143D63
  • Sequence:
  • MATVQQLEGR WRLVDSKGFD EYMKELGVGI ALRKMGAMAK PDCIITCDGK NLTIKTESTL 
    KTTQFSCTLG EKFEETTADG RKTQTVCNFT DGALVQHQEW DGKESTITRK LKDGKLVVEC 
    VMNNVTCTRI YEKVE